Thurayya Arayssi Selected Research

Thurayya Arayssi Research Topics

3	Rheumatoid Arthritis 04/2021 - 08/2009
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2021 - 01/2021
2	Liver Diseases (Liver Disease) 01/2021 - 01/2021
2	Infections 01/2021 - 01/2021
2	Heart Failure 01/2021 - 01/2021
2	Lung Diseases (Lung Disease) 01/2021 - 01/2021
1	Inflammation (Inflammations) 01/2021
1	Genetic Risk Score 01/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2015
1	Behcet Syndrome (Behcet's Syndrome) 05/2014
1	Rheumatic Diseases (Rheumatism) 08/2009
1	Heart Diseases (Heart Disease) 05/2008
1	Dermatomyositis (Dermatopolymyositis) 05/2008
1	Cogan Syndrome 08/2007
1	Pneumonia (Pneumonitis) 02/2007
1	Gangrene 08/2002
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 08/2002
1	Activated Protein C Resistance (APC Resistance) 08/2002
1	Churg-Strauss Syndrome (Allergic Angiitis) 02/2002
1	Asthma (Bronchial Asthma) 02/2002

3	Antirheumatic Agents (DMARD)IBA 01/2021 - 05/2008
2	GlucocorticoidsIBA 01/2021 - 01/2021
2	SteroidsIBA 01/2017 - 02/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2008 - 08/2007
1	amsonic acid (DAS)IBA 04/2021
1	C-Reactive ProteinIBA 01/2021
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2017
1	Amino Acids FDA Link 01/2017
1	Rituximab (Mabthera)FDA Link 05/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2007
1	Protein CIBA 08/2002
1	AntibodiesIBA 08/2002
1	Antinuclear AntibodiesIBA 08/2002
1	Antithrombin IIIIBA 08/2002
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2002
1	Diclofenac (SR 38)FDA LinkGeneric 08/2002
1	Rheumatoid FactorIBA 08/2002
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 08/2002
1	Anticardiolipin AntibodiesIBA 08/2002
1	Protein SIBA 08/2002
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 02/2002

3	Therapeutics 04/2015 - 05/2008
1	Biological Therapy 08/2009